Prestige Consumer Healthcare Inc.
Regulated industryPhysical productsConsumer brandTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $48.22
- 52-Week Range
- $41.77 – $71.07
- Market Cap
- $2.40B
- P/E (TTM)
- 15.62
- EPS (TTM)
- 3.24
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.23
- PEG Ratio
- 1.44
- Return on Equity
- 8.23%
- Return on Assets
- 4.72%
- Gross Margin
- 54.95%
- Operating Margin
- 26.43%
- Profit Margin
- 13.29%
- Current Ratio
- 2.92
- Debt/Equity
- 1.09
- Total Debt
- $2.13B
- Free Cash Flow
- $147.57M
- Revenue Growth
- 22.70%
- Earnings Growth
- -38.40%
- Enterprise Value
- $4.48B
Market Snapshot
About
Prestige Consumer Healthcare Inc. develops, manufactures, and markets over-the-counter healthcare and household cleaning products. The company owns brands including Monistat, Clear Eyes, Chloraseptic, Dramamine, Luden throat drops, Compound W, and Debrox, distributed primarily in North America and Australia.